Cancer Immunology Research | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
Alerts
News
Cancer Hallmarks
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
Cancer Hallmarks
Webinars
10th Anniversary

Skip Nav Destination

Current Issue

Volume 12,

Issue 10

1 October 2024

View This Issue

About the Journal

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. Read More About the Journal

Editors-in-Chief

Robert D. Schreiber
Philip D. Greenberg

View Full Editorial Board

Impact Factor

8.1

SUBMIT TO JOURNAL

Featured Articles

Research Article

Augmenting CAR T-cell Functions with LIGHT

Winson Cai, et al.

Research Article

Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells

Vasyl Eisenberg; Shiran Hoogi, et al.

Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer

Priyanka Yolmo; Sadaf Rahimi, et al.

Trending - Altmetric

The article titled, Complement factor H is an ICOS ligand modulating Tregs in the glioma microenvironment, has an Alt Metric Attention Score of 10.43. Click to see more of this article's metrics.

Read the article titled, Complement factor H is an ICOS ligand modulating Tregs in the glioma microenvironment

Last mentioned on Friday October 11 2024

The article titled, Venetoclax Induces BCL-2-Dependent Treg to TH17 Plasticity to Enhance the Antitumor Efficacy of Anti-PD-1 Checkpoint Blockade., has an Alt Metric Attention Score of 7.75. Click to see more of this article's metrics.

Read the article titled, Venetoclax Induces BCL-2-Dependent Treg to TH17 Plasticity to Enhance the Antitumor Efficacy of Anti-PD-1 Checkpoint Blockade.

Last mentioned on Wednesday October 9 2024

The article titled, Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo, has an Alt Metric Attention Score of 15. Click to see more of this article's metrics.

Read the article titled, Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo

Last mentioned on Tuesday October 8 2024

The article titled, Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors, has an Alt Metric Attention Score of 31.83. Click to see more of this article's metrics.

Read the article titled, Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors

Last mentioned on Tuesday October 8 2024

The article titled, In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates, has an Alt Metric Attention Score of 21. Click to see more of this article's metrics.

Read the article titled, In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates

Last mentioned on Tuesday October 8 2024

Latest
Most Read
Most Cited

Complement factor H is an ICOS ligand modulating Tregs in the glioma microenvironment

Level of expression of MHCI-presented neoepitopes influences tumor rejection by neoantigen-specific CD8+ T cells

Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity

Transient EZH2 suppression by Tazemetostat during in vitro expansion maintains T-cell stemness and improves adoptive T-cell therapy

Issues
Online First
News
Twitter

Online ISSN 2326-6074
Print ISSN 2326-6066

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Information on Advertising & Reprints
Information for Institutions/Librarians
RSS Feeds
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2023 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept